Showing results (311-320 of 322) with videos related to
Sort By:
Pageof 33
Surgery|January 1, 1986
Analysis of the risk reduction of prophylactic partial mastectomy in Sprague-Dawley rats with 7,12-dimethylbenzanthracene-induced breast cancerJ H Wong, C F Jackson, J S Swanson, et al.Protein Engineering|January 1, 1992
Biochemical properties of the kringle 2 and protease domains are maintained in the refolded t-PA deletion variant BM 06.022U Kohnert, R Rudolph, J H Verheijen, et al.Psychopharmacology Bulletin|January 1, 1996
Venlafaxine for panic disorder: results from a double-blind, placebo-controlled studyM H Pollack, J J Worthington, M W Otto, et al.Structure (London, England : 1993)|November 15, 1996
Enzyme flexibility, solvent and 'weak' interactions characterize thrombin-ligand interactions: implications for drug designR A Engh, H Brandstetter, G Sucher, et al.Transplantation|March 27, 1997
Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenograftsS K Pruitt, R R Bollinger, B H Collins, et al.The Journal of Clinical Investigation|September 1, 1995
Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing woundsG F Pierce, J E Tarpley, J Tseng, et al.Ground Water|January 6, 2016
Use of an Artificial Sweetener to Identify Sources of Groundwater Nitrate ContaminationW D Robertson, D R Van Stempvoort, J W Roy, et al.Neurology|February 28, 2007
Safety and feasibility of long-term temozolomide treatment in patients with high-grade gliomaP Hau, D Koch, T Hundsberger, et al.The Annals of Thoracic Surgery|March 1, 1993
Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypassA M Gillinov, P A DeValeria, J A Winkelstein, et al.Transplantation|February 1, 1994
The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenograftsS K Pruitt, A D Kirk, R R Bollinger, et al.Pageof 33